BioSpace News Archive

Endo International plc announced today that members of management will participate in a fireside chat at the Bank of America Merrill Lynch Leveraged Finance Conference in Boca Raton, Florida on Tuesday, December 4, 2018 at 9:30 a.m. ET.

At a meeting with analysts and investors at its Investor Day tomorrow, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, will discuss the company’s two-point strategy and range of initiatives underway to accelerate growth and drive operational excellence, and also will outline its near-and long-term financial outlook.

Cardax, Inc. announced that Paresh N. Soni, M.D., Ph.D., the former Senior Vice President and Head of Development for Amarin Corporation, will join Cardax as Chief Clinical and Regulatory Strategist and as a member of the Company’s Scientific Advisory Board.

The first-ever awards took place in Senegal to mark progress in African healthcare innovation and leadership

SpendEdge, a well-known procurement intelligence solution provider, has announced the completion of their price fluctuation analysis for a pharma industry client

In the news release, Cannabics Pharmaceuticals Announces New Provisional Patent Application for Magnetic Targeting of Cannabinoids, issued Nov. 28, 2018 by Cannabics Pharmaceuticals Inc. over PR Newswire, we are advised by the company that the original release was issued inadvertently with imprecise information.

HSA Bank, a division of Webster Bank, N.A., released a report today that addresses how consumers are saving for healthcare expenses in retirement.

To culminate lung cancer awareness month, St. Elizabeth Healthcare thoracic surgeon, Dr. Royce Calhoun, will narrate a complex lung cancer surgery he previously performed, live on Facebook.

Physicians’ Education Resource® (PER®), the nation’s leading resource for oncology and hematology continuing medical education (CME), will host its second annual Precision Medicine Through Plasma: Using Liquid Biopsies in Contemporary Oncology Care workshop on Saturday, Dec. 8 at the Convene in New York City.

First dose of potential treatment AT-1501 given to humans by Anelixis Therapeutics to determine safety and tolerability